References
- V. Kumar and K. Roy, Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases, SAR QSAR Environ. Res. 31 (2020), pp. 511–526. doi:https://doi.org/10.1080/1062936X.2020.1776388.
- A. Arwansyah, A.R. Arif, I. Ramli, I. Kurniawan, S. Sukarti, M. Nur Alam, I. Illing, A. Farid Lewa, and B. Manguntungi, Molecular modelling on SARS-CoV-2 papain-like protease: An integrated study with homology modelling, molecular docking, and molecular dynamics simulations, SAR QSAR Environ. Res. 32 (2021), pp. 699–718. doi:https://doi.org/10.1080/1062936X.2021.1960601.
- WHO Coronavirus (COVID-19) Dashboard. Available at https://covid19.who.int/ (accessed 10 February 2022).
- Center for disease control and prevention, Stay up to date with your COVID-19 vaccines. Available at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html (accessed 1 January 2022).
- A. Artese, V. Svicher, G. Costa, R. Salpini, V.C. Di Maio, M. Alkhatib, F.A. Ambrosio, M.M. Santoro, Y.G. Assaraf, and S. Alcaro, Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses, Drug Resist. Updat. 53 (2020), pp. 100721. doi:https://doi.org/10.1016/j.drup.2020.100721.
- M.-Y. Wang, R. Zhao, L.-J. Gao, X.-F. Gao, D.-P. Wang, and J.-M. Cao, SARS-CoV-2: Structure, biology, and structure-based therapeutics development, Front. Cell. Infect. Microbiol. 10 (2020), pp. 587269. doi:https://doi.org/10.3389/fcimb.2020.587269.
- B. Sepehri, M. Kohnehpoushi, and R. Ghavami, High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors, J. Iran. Chem. Soc. (2021). doi:https://doi.org/10.1007/s13738-021-02426-2.
- N. Adhikari, S. Banerjee, S.K. Baidya, B. Ghosh, and T. Jha, Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CLpro inhibitors: Theoretical justification in light of experimental evidences, SAR QSAR Environ. Res. 32 (2021), pp. 473–493. doi:https://doi.org/10.1080/1062936X.2021.1914721.
- D. Kumar, G. Chauhan, S. Kalra, B. Kumar, and M.S. Gill, A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules, Bioorg. Chem. 104 (2020), pp. 104326. doi:https://doi.org/10.1016/j.bioorg.2020.104326.
- C. Gil, T. Ginex, I. Maestro, V. Nozal, L. Barrado-Gil, M.Á. Cuesta-Geijo, J. Urquiza, D. Ramírez, C. Alonso, and N.E. Campillo, COVID-19: Drug targets and potential treatments, J. Med. Chem. 63 (2020), pp. 12359–12386. doi:https://doi.org/10.1021/acs.jmedchem.0c00606.
- H.M. Mengist, T. Dilnessa, and T. Jin, Structural basis of potential inhibitors targeting SARS-CoV-2 main protease, Front. Chem. 9 (2021), pp. 622898. doi:https://doi.org/10.3389/fchem.2021.622898.
- S. Ullrich and C. Nitsche, The SARS-CoV-2 main protease as drug target, Bioorg. Med. Chem. Lett. 30 (2020), pp. 127377. doi:https://doi.org/10.1016/j.bmcl.2020.127377.
- H. Yang and Z. Rao, Structural biology of SARS-CoV-2 and implications for therapeutic development, Nat. Rev. Microbiol. 19 (2021), pp. 685–700. doi:https://doi.org/10.1038/s41579-021-00630-8.
- M.E. Sobhia, G.S. Kumar, S. Sivangula, K. Ghosh, H. Singh, T. Haokip, and J. Gibson, Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors, Future Med. Chem. 13 (2021), pp. 1435–1450. doi:https://doi.org/10.4155/fmc-2020-0264.
- B. Sepehri and R. Ghavami, The identification of new ATAD2 bromodomain inhibitors: The application of combined ligand and structure-based virtual screening, SAR QSAR Environ. Res. 28 (2017), pp. 957–971. doi:https://doi.org/10.1080/1062936X.2017.1385532.
- B. Sepehri, M. Rezaei, and R. Ghavami, The in silico identification of potent anti-cancer agents by targeting the ATP binding site of the N-domain of HSP90, SAR QSAR Environ. Res. 29 (2018), pp. 551–565. doi:https://doi.org/10.1080/1062936X.2018.1494626.
- P.D. Lyne, Structure-based virtual screening: An overview, Drug Discov. Today 7 (2002), pp. 1047–1055. doi:https://doi.org/10.1016/S1359-6446(02)02483-2.
- P. Ripphausen, B. Nisius, and J. Bajorath, State-of-the-art in ligand-based virtual screening, Drug Discov. Today 16 (2011), pp. 372–376. doi:https://doi.org/10.1016/j.drudis.2011.02.011.
- D.E. Clark, What has virtual screening ever done for drug discovery?, Expert Opin. Drug discov. 3 (2008), pp. 841–851. doi:https://doi.org/10.1517/17460441.3.8.841.
- D.V. Green, Virtual screening of chemical libraries for drug discovery, Expert Opin. Drug Discov. 3 (2008), pp. 1011–1026. doi:https://doi.org/10.1517/17460441.3.9.1011.
- https://www.rcsb.org/structure/7L0D (accessed 5 December 2021).
- G.J. Lockbaum, A.C. Reyes, J.M. Lee, R. Tilvawala, E.A. Nalivaika, A. Ali, N. Kurt Yilmaz, P.R. Thompson, and C.A. Schiffer, Crystal structure of SARS-CoV-2 main protease in complex with the non-covalent inhibitor ML188, Viruses 13 (2021), pp. 174. doi:https://doi.org/10.3390/v13020174.
- https://www.rcsb.org/structure/6w63 (accessed 5 December 2021).
- https://www.rcsb.org/structure/7ju7 (accessed 5 December 2021).
- N. Drayman, J.K. DeMarco, K.A. Jones, S.-A. Azizi, H.M. Froggatt, K. Tan, N.I. Maltseva, S. Chen, V. Nicolaescu, S. Dvorkin, K. Furlong, R.S. Kathayat, M.R. Firpo, V. Mastrodomenico, E.A. Bruce, M.M. Schmidt, R. Jedrzejczak, M.Á. Muñoz-Alía, B. Schuster, V. Nair, K.-Y. Han, A. O’Brien, A. Tomatsidou, B. Meyer, M. Vignuzzi, D. Missiakas, J.W. Botten, C.B. Brooke, H. Lee, S.C. Baker, B.C. Mounce, N.S. Heaton, W.E. Severson, K.E. Palmer, B.C. Dickinson, A. Joachimiak, G. Randall, and S. Tay, Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2, Science 373 (2021), pp. 931–936. doi:https://doi.org/10.1126/science.abg5827.
- K.-C. Hsu, Y.-F. Chen, S.-R. Lin, and J.-M. Yang, iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis, BMC Bioinf. 12 (2011), pp. S33. doi:https://doi.org/10.1186/1471-2105-12-S1-S33.
- N.M. O’Boyle, M. Banck, C.A. James, C. Morley, T. Vandermeersch, and G.R. Hutchison, Open babel: An open chemical toolbox, J. Chem. Inf. 3 (2011), pp. 33-33. doi:https://doi.org/10.1186/1758-2946-3-33.
- HyperChem 7.1, Hypercube, Inc., Gainesville, USA; software available at http://www.hyper.com (accessed 30 August 2021).
- MGLTools 1.5.6, Molecular Graphics Laboratory (MGL) of the Scripps Research Institute, LaJolla, USA, 2012; software available at http://mgltools.scripps.edu (accessed 30 August 2021).
- O. Trott and A.J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem. 31 (2010), pp. 455–461. doi:https://doi.org/10.1002/jcc.21334.
- Discovery studio 16.1.0, Accelrys, BIOVIA, San Diego, USA; software available at www.accelrys.com (accessed 30 August 2021).
- Gaussian 09, Gaussian, Inc., Wallingford CT; software available at https://gaussian.com/glossary/g09/ (accessed 30 August 2021).
- Amber 18, University of California, San Francisco; software available at http://ambermd.org/AmberMD.php (accessed 30 August 2021).
- H. Li, K.-S. Leung, M.-H. Wong, and P.J. Ballester, USR-VS: A web server for large-scale prospective virtual screening using ultrafast shape recognition techniques, Nucleic Acids Res. 44 (2016), pp. W436–W441. doi:https://doi.org/10.1093/nar/gkw320.
- P.J. Ballester and W.G. Richards, Ultrafast shape recognition to search compound databases for similar molecular shapes, J. Comput. Chem. 28 (2007), pp. 1711–1723. doi:https://doi.org/10.1002/jcc.20681.
- A. Daina, O. Michielin, and V. Zoete, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017), pp. 42717. doi:https://doi.org/10.1038/srep42717.
- P. Banerjee, A.O. Eckert, A.K. Schrey, and R. Preer, ProTox-II: A webserver for the prediction of toxicity of chemicals, Nucleic Acids Res. 46 (2018), pp. W257–W263. doi:https://doi.org/10.1093/nar/gky318.
- J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:https://doi.org/10.1021/acs.jctc.5b00255.
- J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general Amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:https://doi.org/10.1002/jcc.20035.
- A.D. Becke, Density-functional exchange-energy approximation with correct asymptotic-behavior, Phys. Rev. A 38 (1988), pp. 3098–3100. doi:https://doi.org/10.1103/PhysRevA.38.3098.
- C. Lee, W. Yang, and R.G. Parr, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Phys. Rev. B 37 (1988), pp. 785–789. doi:https://doi.org/10.1103/PhysRevB.37.785.
- G.A. Petersson, A. Bennett, T.G. Tensfeldt, M.A. Al‐Laham, W.A. Shirley, and J. Mantzaris, A complete basis set model chemistry. I. The total energies of closed‐shell atoms and hydrides of the first‐row elements, J. Chem. Phys. 89 (1988), pp. 2193–2218. doi:https://doi.org/10.1063/1.455064.
- G.A. Petersson and M.A. Al‐Laham, A complete basis set model chemistry. II. Open‐shell systems and the total energies of the first‐row atoms, J. Chem. Phys. 94 (1991), pp. 6081–6090. doi:https://doi.org/10.1063/1.460447.
- A.D. Becke, Density-functional thermochemistry. III. The role of exact exchange, J. Chem. Phys. 98 (1993), pp. 5648–5652. doi:https://doi.org/10.1063/1.464913.
- C.I. Bayly, P. Cieplak, W. Cornell, and P.A. Kollman, A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model, J. Phys. Chem. 97 (1993), pp. 10269–10280. doi:https://doi.org/10.1021/j100142a004.
- B.H. Besler, K.M. Merz, and P.A. Kollman, Atomic charges derived from semiempirical methods, J. Comput. Chem. 11 (1990), pp. 431–439. doi:https://doi.org/10.1002/jcc.540110404.
- S. Jafari, U. Ryde, and M. Irani, QM/MM study of the catalytic reaction of myrosinase; importance of assigning proper protonation states of active-site residues, J. Chem Theory Comput. 17 (2021), pp. 1822–1841. doi:https://doi.org/10.1021/acs.jctc.0c01121.
- W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935. doi:https://doi.org/10.1063/1.445869.
- X. Wu and B.R. Brooks, Self-guided Langevin dynamics simulation method, Chem. Phys. Lett. 381 (2003), pp. 512–518. doi:https://doi.org/10.1016/j.cplett.2003.10.013.
- H.J.C. Berendsen, J.P.M. Postma, W.F. van Gunsteren, A. DiNola, and J.R. Haak, Molecular dynamics with coupling to an external bath, J. Chem. Phys. 81 (1984), pp. 3684–3690. doi:https://doi.org/10.1063/1.448118.
- T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:https://doi.org/10.1063/1.464397.
- J.P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes, J. Comput. Phys 23 (1977), pp. 327–341. doi:https://doi.org/10.1016/0021-9991(77)90098-5.
- D.R. Roe and T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095. doi:https://doi.org/10.1021/ct400341p.
- D. Panigrahi and G.P. Mishra, Virtual screening, molecular docking and In-silico ADME-Tox analysis for identification of potential main protease (Mpro) enzyme inhibitors, Antiinfect. Agents 19 (2021), pp. 11–27. doi:https://doi.org/10.2174/2211352518999201208201854.